MARKET

TLX

TLX

Telix Pharmaceuticals Ltd ADR
NASDAQ
10.56
-0.30
-2.76%
After Hours: 10.77 +0.21 +1.99% 19:25 05/15 EDT
OPEN
10.68
PREV CLOSE
10.86
HIGH
10.78
LOW
10.24
VOLUME
80.25K
TURNOVER
--
52 WEEK HIGH
18.49
52 WEEK LOW
6.28
MARKET CAP
3.58B
P/E (TTM)
-500.4739
1D
5D
1M
3M
1Y
5Y
1D
Telix, EDAP And Profound Partner To Explore PSMA-PET Imaging In Prostate Cancer Treatment
NASDAQ · 1d ago
Telix Pharma Enters Into LOI To Pursue Collaborations With EDAP And Profound Medical To Explore Investigational Use Of Telix's PSMA-PET1 Imaging Agents Gozellix And Illuccix With Robotic HIFU, And Other Image-Guided Therapies To Treat Prostate Cancer
Benzinga · 1d ago
TELIX ANNOUNCES COLLABORATIONS TO EXPLORE PSMA-PET IMAGING IN EMERGING PROSTATE CANCER TREATMENT APPROACHES
Reuters · 1d ago
Weekly Report: what happened at TLX last week (0504-0508)?
Weekly Report · 5d ago
Telix CEO Christian Behrenbruch acquires ordinary shares worth AUD 1.01 million
PUBT · 05/07 01:32
Telix says analysis of Phase 3 ZIRCON data expands TLX250-Px kidney cancer detection
PUBT · 05/04 21:18
Telix Pharmaceuticals' TLX250-Px PET/CT Demonstrates High Predictive Accuracy Across All Renal Cancer Subtypes In Phase 3 ZIRCON Trial Analysis
Benzinga · 05/04 21:03
Telix study shows Zircaix PET/CT predicts kidney cancer beyond clear-cell RCC
PUBT · 05/04 21:00
More
About TLX
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Webull offers Telix Pharmaceuticals Ltd stock information, including NASDAQ: TLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLX stock methods without spending real money on the virtual paper trading platform.